KPV 10 mg

KPV, consisting of the amino acids Lys-Pro-Val (Lysine-Proline-Valine), is the C-terminal tripeptide sequence of α-MSH. Unlike the full α-MSH molecule, KPV lacks the broader melanocortin receptor-binding sequence and has been investigated as an independent research peptide. The 10 mg presentation is intended for qualified research environments conducting controlled investigations into peptide pharmacology, cellular signaling, inflammatory-response pathways, and related molecular mechanisms.

Key Features

10 mg research-grade KPV Lys-Pro-Val tripeptide C-terminal sequence of α-MSH Relevant to inflammatory signaling research Suitable for cellular and molecular pathway studies Intended for controlled in-vitro and preclinical research Appropriate for peptide characterization and analytical workflows Batch-level analytical documentation may be provided for applicable lots Research Focus KPV has been investigated in laboratory and animal models for its relationship with inflammatory signaling pathways. Experimental research has reported effects on inflammatory-cell migration and cytokine-associated responses, with some findings suggesting mechanisms that may occur independently of classical melanocortin receptor activation. Research has also examined KPV in models of intestinal inflammation and epithelial inflammatory signaling. These findings remain primarily preclinical and should not be interpreted as evidence of established human therapeutic efficacy.

Important Notice

This product is supplied strictly for research and laboratory use. It is not intended for human or veterinary use, self-administration, consumption, diagnosis, treatment, or prevention of disease. This research material should be handled only by appropriately qualified personnel in accordance with applicable laboratory protocols, analytical requirements, and regulations.